It is somewhat surprising that the prevalence of PSA testing and early-stage prostate cancer did not differ by exposure status, given that veterans with self-reported exposure were invited to undergo PSA testing and digital rectal examination; therefore, one might expect that exposed veterans would be more likely to undergo these procedures than the non-exposed. The gene discussed is KLK3; the disease is prostate carcinoma.